Edition:
United States

Portola Pharmaceuticals Inc (PTLA.OQ)

PTLA.OQ on NASDAQ Stock Exchange Global Select Market

20.68USD
7 Dec 2018
Change (% chg)

-- (--)
Prev Close
$20.68
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
477,950
52-wk High
$56.66
52-wk Low
$18.19

Chart for

About

Portola Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of therapeutics in the areas of thrombosis, other hematologic disorders and inflammation for patients having limited or no approved treatment options. The Company's two lead programs, Betrixaban and... (more)

Overall

Beta: 2.00
Market Cap(Mil.): $1,324.03
Shares Outstanding(Mil.): 66.43
Dividend: --
Yield (%): --

Financials

  PTLA.OQ Industry Sector
P/E (TTM): -- 95.96 30.88
EPS (TTM): -5.38 -- --
ROI: -74.84 0.60 13.80
ROE: -119.72 -2.18 15.29

Earnings vs. Estimates